(R)-CR8
Cat.No:IC6380 Solarbio
CAS:294646-77-8
Molecular Formula:C24H29N7O
Molecular Weight:431.53
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Cell Cycle >
(R)-CR8CAS:294646-77-8
Molecular Formula:C24H29N7O
Molecular Weight:431.53
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 294646-77-8 |
Name | (R)-CR8 |
Molecular Formula | C24H29N7O |
Molecular Weight | 431.53 |
Solubility | Soluble in DMSO ≥10mg/mL(Need ultrasonic or Water bath) |
Purity | ≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD18785641 |
SMILES | CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=C(C=C3)C4=CC=CC=N4 |
InChIKey | HOCBJBNQIQQQGT-LJQANCHMSA-N |
InChI | InChI=1S/C24H29N7O/c1-4-19(14-32)28-24-29-22(21-23(30-24)31(15-27-21)16(2)3)26-13-17-8-10-18(11-9-17)20-7-5-6-12-25-20/h5-12,15-16,19,32H,4,13-14H2,1-3H3,(H2,26,28,29,30)/t19-/m1/s1 |
PubChem CID | 10224714 |
Target Point | CDK1/2/5/7/9 |
Passage | Cell Cycle |
Background | (R) -CR8 is a potent inhibitor of CDK1/2/5/7/9. |
Biological Activity | (R) - CR8 (CR8),a second-generation analog of Roscovitine,is a potent CDK1/2/5/7/9 inhibitor. (R) - CR8 inhibits CDK1/cyclin B (IC50=0.09 μM),CDK2/cyclin A (0.072 μM),CDK2/cyclin E (0.041 μM),CDK5/p25 (0.11 μM),CDK7/cyclin H (1.1 μM),CDK9/cyclin T (0.18 μM) and CK1δ/ε (0.4 μM). (R) - CR8 induces apoptosis and has neuroprotective effect.(R)-CR8 acts as a molecular glue degrader that depletes cyclin K[1-3]. |
Data Literature Source | [1]. Bettayeb K,et al. CR8,a potent and selective,roscovitine-derived inhibitor of cyclin-dependent kinases. Oncogene. 2008 Oct 2;27(44):5797-807. [2]. Kabadi SV,et al. CR8,a novel inhibitor of CDK,limits microglial activation,astrocytosis,neuronal loss,and neurologic dysfunction after experimental traumatic brain injury. J Cereb Blood Flow Metab. 2014 Mar;34(3):502-13. [3]. S abicki M,et al. The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K [published online ahead of print,2020 Jun 3]. Nature. 2020;10.1038/s41586-020-2374-x. |
Unit | Bottle |
Specification | 1mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.